296 related articles for article (PubMed ID: 11052177)
1. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
Kaca W; Literacka E; Sjöholm AG; Weintraub A
J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
[TBL] [Abstract][Full Text] [Related]
2. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
[TBL] [Abstract][Full Text] [Related]
3. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
[TBL] [Abstract][Full Text] [Related]
4. The factor C3 conversion in human complement by smooth Shigella flexneri lipopolysaccharides.
Fudała R; Doroszkiewicz W; Niedbach J; Gamian A; Weintraub A; Kaca W
Acta Microbiol Pol; 2003; 52(1):45-52. PubMed ID: 12916727
[TBL] [Abstract][Full Text] [Related]
5. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
[TBL] [Abstract][Full Text] [Related]
6. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
[TBL] [Abstract][Full Text] [Related]
7. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13.
Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W
Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical studies on the O-antigens of Proteus mirabilis O23 and Proteus vulgaris O23.
Rózalski A; Perepelov AV; Bartodziejska B; Senchenkova SN; Babicka D; Kaca W; Knirel YA
Arch Immunol Ther Exp (Warsz); 2003; 51(1):69-74. PubMed ID: 12691306
[TBL] [Abstract][Full Text] [Related]
9. Human anti-scrub typhus rickettsia and rabbit anti-Proteus antibodies recognize similar epitope in the O-polysaccharide part of Proteus mirabilis OXK lipopolysaccharide.
Kaca W; Amano K; Chernyak AY; Knirel YA
Microbios; 2000; 103(406):151-61. PubMed ID: 11131808
[TBL] [Abstract][Full Text] [Related]
10. The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis.
Arabski M; Fudala R; Koza A; Wasik S; Futoma-Koloch B; Bugla-Ploskonska G; Kaca W
Clin Biochem; 2012 Nov; 45(16-17):1374-82. PubMed ID: 22749779
[TBL] [Abstract][Full Text] [Related]
11. Classification of Proteus mirabilis TG 115 and CCUG 10701 into the Proteus O23 serogroup based on chemical and serological studies of O-polysaccharides.
Zabłotni A; Perepelov AV; Kołodziejska K; Zych K; Knirel YA; Sidorczyk Z
Arch Immunol Ther Exp (Warsz); 2006; 54(6):411-7. PubMed ID: 17122881
[TBL] [Abstract][Full Text] [Related]
12. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
[TBL] [Abstract][Full Text] [Related]
13. [Tests for studying invasive properties of selected Proteus mirabilis strains].
Bartodziejska B; Wykrota M; Rózalski A; Kaca W
Med Dosw Mikrobiol; 2001; 53(3):277-82. PubMed ID: 11785185
[TBL] [Abstract][Full Text] [Related]
14. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
[TBL] [Abstract][Full Text] [Related]
15. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
[TBL] [Abstract][Full Text] [Related]
16. Serological characterization of the O-specific polysaccharide of Providencia alcalifaciens O23.
Torzewska A; Kocharova NA; Maszewska A; Knirel YA; Rózalski A
Arch Immunol Ther Exp (Warsz); 2004; 52(1):43-9. PubMed ID: 15053232
[TBL] [Abstract][Full Text] [Related]
17. Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix test.
Swierzko AS; Cedzynski M; Knirel YuA ; Senchenkova SN; Kocharova NA; Shashkov AS; Amano KI; Kyohno K; Kaca W
Biochemistry (Mosc); 1997 Jan; 62(1):21-7. PubMed ID: 9113725
[TBL] [Abstract][Full Text] [Related]
18. Structure of the neutral O-polysaccharide and biological activities of the lipopolysaccharide of Proteus mirabilis O20.
Kondakova AN; Fudala R; Bednarska K; Senchenkova SN; Knirel YA; Kaca W
Carbohydr Res; 2004 Feb; 339(3):623-8. PubMed ID: 15013399
[TBL] [Abstract][Full Text] [Related]
19. The comparison of some biological activities of lipopolysaccharides obtained from smooth and rough Proteus mirabilis strains.
Klink M; Brzychcy M; Ziółkowski A; Swierzko A; Sułowska Z; Cedzyński M; Tchórzewski H
Acta Microbiol Pol; 1998; 47(2):141-51. PubMed ID: 9839373
[TBL] [Abstract][Full Text] [Related]
20. Structure of the glycerol phosphate-containing O-polysaccharides and serological studies of the lipopolysaccharides of Proteus mirabilis CCUG 10704 (OE) and Proteus vulgaris TG 103 classified into a new Proteus serogroup, O54.
Kołodziejska K; Perepelov AV; Zabłotni A; Drzewiecka D; Senchenkova SN; Zych K; Shashkov AS; Knirel YA; Sidorczyk Z
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):267-74. PubMed ID: 16831214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
